🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
JNJ
NYSE
🇺🇸 US
Johnson & Johnson
Healthcare
20Score
DipBuster Score™
$232.74
+$4.57001 (+0%)
Live price · Source: FMP-live
52-Week Position
$149.04
82% of range
$251.71
Beta
0.263
Low vol
Dividend
—
no income
Mkt Cap
$560.26B
total value
Mkt Cap$560.26B
P/EN/A
DividendNone
Beta0.263
52W High$251.71
52W Low$149.04
🤖
Not a Dip — Score 20/100
Zone: Consider Trimming
🔒 Unlock Pro
Valuation
P/E Ratio—
Mkt Cap$560.26B
52W Position82% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.263
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️
Insider Buys
Track director & CEO open-market purchases
📊
Valuation Analysis
P/E, EV/EBITDA, DCF & NCAV metrics
📈
Financial Charts
Revenue, EBITDA, FCF & balance sheet trends
🤖
AI Analysis
Plain-English explanation of every key metric
Sign up free — charts & fundamentals included
Get financial charts, valuation data, dividends & news for Johnson & Johnson free. Upgrade to Pro for insider signals & AI analysis.
Sponsored · FCA Regulated Broker
Trading 212
Commission-free investing. ISA and GIA available. FCA regulated.
Free share worth up to £100 when you sign up
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
7/25
Momentum & Volume
8/25
Quality & Size
5/10
Insider Activity
0/10
Quick Take
⚪
Not a Dip
DipBuster Score: 20/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue…
Sector
Healthcare
Market
🇺🇸 US
CEO
Joaquin Duato
Staff
138,100 employees
Website